CLTS Financials 07/15/2014 18:58:36
Earth Life Sciences Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 80 50 16 10
Cost of Revenue - - - -
Gross Profit 80 50 16 10
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 155 217 221 77
Non-Recurring Items - - - -
Other 1 1 1 -
Operating Income (91) (184) (207) (67)
Income From Continuing Operations
Add'l Income/Expense Items 18 18 7 23
Earnings Before Interest and Tax (58) (149) (200) (45)
Interest Expense 15 17 9 11
Earnings Before Tax (73) (166) (208) (56)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (73) (166) (208) (56)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (73) (166) (208) (56)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (73) (166) (208) (56)